Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumor Liver”

948 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 948 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Not applicableStudy completedNCT01353300
What this trial is testing

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Who this might be right for
Brain and Central Nervous System TumorsHereditary Wilms TumorKidney Cancer+4 more
Children's Oncology Group 31
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT03783871
What this trial is testing

NeuWave Microwave Ablation HCC China Study

Who this might be right for
Liver TumorHepatocellular Carcinoma
Ethicon, Inc. 135
Not applicableActive Not RecruitingNCT06632106
What this trial is testing

HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

Who this might be right for
Hepatic Arterial Infusion ChemotherapyTyrosine Kinase InhibitorImmune Checkpoint Inhibitors+1 more
First Hospital of China Medical University 97
Not applicableNot Yet RecruitingNCT07459309
What this trial is testing

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Who this might be right for
Liver Cancer (Primary and Metastatic)Liver Ablation
Fudan University 20
Not applicableLooking for participantsNCT07504367
What this trial is testing

Large Language Models Assist in Tumor MDT

Who this might be right for
Lung CancerBreast CancerColorectal Cancer+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Not applicableStudy completedNCT06779734
What this trial is testing

Radiomics of Colorectal Liver Metastases: Identification of New Prognostic Biomarkers.

Who this might be right for
Liver Metastases From Colorectal Cancer (mCRC)
Istituto Clinico Humanitas 400
Not applicableWithdrawnNCT02599909
What this trial is testing

Gut Microbiota in People With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Cell Caricinoma+1 more
National Cancer Institute (NCI)
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Not applicableLooking for participantsNCT06594289
What this trial is testing

Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy

Who this might be right for
Liver Tumor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 220
Not applicableLooking for participantsNCT02838836
What this trial is testing

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerGastric Cancer+3 more
University of Missouri-Columbia 620
Not applicableStudy completedNCT06060899
What this trial is testing

Intraoperative Blood Loss Under Standard Versus Low Pneumoperitoneum Pressure During Laparoscopic Liver Resection.

Who this might be right for
Liver Tumor
Medical University of Warsaw 36
Not applicableEnded earlyNCT03889093
What this trial is testing

Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

Who this might be right for
Hepatocellular CarcinomaSecondary Malignant Neoplasm of Liver
University of Minnesota 14
Early research (Phase 1)Study completedNCT04676633
What this trial is testing

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCholangiocarcinoma
Sirnaomics 5
Load More Results